COMMUNIQUÉS West-GlobeNewswire

Informations relatives aux activités de stabilisation menées dans le cadre de sa récente offre au public
24/11/2025
Daix (France), New York City (New York, États-Unis), le 24 novembre 2025 - Publication d'informations relatives aux activités de stabilisation menées dans le cadre de la récente offre au public d'Inventiva (la "Société [...]
Information relating to the stabilization activities carried out in the context of its recent offering
24/11/2025
Daix (France), New York City (New York, United States), November 24, 202 5 – Publication of information relating to the stabilization activities carried out in the context of the recent public offering of Inventiva (the [...]
Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting
24/11/2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system (CNS) [...]
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference
24/11/2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
24/11/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Sana Biotechnology to Present at December 2025 Investor Conferences
24/11/2025
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Rani Therapeutics to Participate in the Evercore Healthcare Conference
24/11/2025
SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
NANOBIOTIX fait le point sur sa trésorerie et son activité opérationnelle du troisième trimestre 2025 et partage des perspectives cliniques pour 2026
24/11/2025
Base financière posée dans la perspective d’une autonomie financière et d’une croissance à long-terme via la finalisation de l’accord de financement non-dilutif de partage de redevances ( royalty financing ) avec [...]
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
24/11/2025
Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty (“HCRx”) of a non-dilutive royalty financing valued up to $71 million Progress in the JNJ-1900 (NBTXR3) [...]
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
24/11/2025
VALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that the Company will [...]
Tarsus to Participate in Upcoming Investor Conference
24/11/2025
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the BTIG 5 th Annual Ophthalmology Day on Monday, [...]
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
24/11/2025
DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Ultragenyx to Participate in Investor Conferences in December
24/11/2025
NOVATO, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Onco360® Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO® (sevabertinib)
24/11/2025
LOUISVILLE, Ky., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for HYRNUO ® (sevabertinib [...]
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
24/11/2025
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studies One-time [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2025
24/11/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
CARBIOS signe deux nouveaux engagements commerciaux pluriannuels de PET biorecyclé avec des acteurs majeurs de la boisson
24/11/2025
Clermont-Ferrand (France), 24 novembre 2025 (18h30 CET). CARBIOS (Euronext Growth Paris : ALCRB), annonce la signature de deux nouveaux engagements commerciaux pluriannuels avec des acteurs majeurs de la boisson, pour [...]
CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry
24/11/2025
Clermont-Ferrand (France), 24 November 2025 (18h30 CET). CARBIOS (Euronext Growth Paris : ALCRB), announces the signing of two new multi-year commercial agreements with major players in beverage industry, for the supply [...]
Press release: Transparency Notification from Shareholders
24/11/2025
Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders Ghent, Belgium – 24 November 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer [...]

Pages